Skip to main content

Let’s Talk About CAR T-Cell Therapy as a Treatment Option: Blood Cancers

January 29, 2024

We invite you to learn more about:

  • The process of CAR T-cell therapy
  • Eligibility for CAR T-cell therapy
  • Side effects and recovery after CAR T-cell therapy
  • Maintaining quality of life after CAR T-cell therapy

Monalisa Ghosh, MD

Clinical Associate Professor
University of Michigan Health
Ann Arbor, MI

 

Program Support

Support for this program is provided by Bristol Myers Squibb; Janssen Oncology & Legend Biotech; and Kite, a Gilead Company.

See All Resources

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.